Alpha/Beta T Cell and CD19+ B Cell Depletion

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

More Information

Trial Status
Not yet accepting
Trial Phase
Phase 2
Enrollment
20 patients (estimated)
Sponsors
University of Florida Health Cancer Center
Collaborators
Ocala Royal Dames for Cancer Research
Tags
Allogeneic Stem Cell Transplant
Trial Type
Treatment
Last Update
1 month ago
SparkCures ID
1873
NCT Identifier
NCT05800210

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.